eSonic Medical (ESI) was founded in China by French academician and worldwide acoustics expert Jacques Souquet. The company is dedicated to researching and manufacturing the latest Elastography Ultrasound equipment globally, which is the third-generation technology following B-mode and color Doppler ultrasound. This technology is internationally advanced. Due to its system platform is hundreds of times faster than conventional color Doppler ultrasound (so referred to as "5G" ultrasound), it possesses unique "quantitative," "objective," and "visual" technological advantages and clinical value, quickly gaining recognition from a large number of doctors.
The company has introduced the first Elastography Ultrasound equipment in China, capable of achieving precise quantitative diagnosis at the level of ultrasound biomarkers (Biomarkers), significantly improving the diagnostic accuracy of various major diseases such as chronic liver disease, tumors, and cardiovascular and cerebrovascular diseases. It completes tissue quantitative analysis that conventional color Doppler ultrasound cannot achieve, effectively reducing invasive examinations, filling domestic gaps. It provides a basis for early quantitative diagnosis of various major diseases, which is of great significance to public health.
The company has now developed three categories of Elastography Ultrasound products: Portable, Portable on Cart, and Cart-base. ESI Medical (ESI), adhering to its international heritage, continues to innovate and disrupt, focusing on China while looking globally, committed to combining leading global technology with Chinese manufacturing seamlessly.
eSonic Medical Technology (ESI, hereinafter referred to as eSonic) has brought in leading scientists in the field of ultrasound from Europe and the United States and gathered top domestic research and development elites to seamlessly integrate the worlds leading ultrasound technology with Chinese manufacturing, providing more comprehensive and perfect ultrasound solutions for various clinical scenarios both inside and outside hospitals. Committed to promoting quantitative elastography ultrasound as a reliable and popular means for health management, disease diagnosis and treatment, and therapeutic efficacy evaluation.
eSonic also has abundant clinical research cooperation resources, maintaining close connections and collaboration with several top domestic research institutions and universities. Upholding the development concept of providing truly world-class ultrasound imaging products for the Chinese and international markets, eSonic is leading the trend of medical ultrasound technology development at home and abroad.